ESR1 and breast cancer: The results showed no significant association between ELF-EMF exposure and female breast cancer risk in total analysis (OR = 0.988, 95% CI = 0.898–1.088) and in all the subgroup analyses by exposure modes, menopausal status, and estrogen receptor status.